PhRMA Files a Lawsuit Over Medicare Drug Price Negotiations

The pharmaceutical industry’s largest lobbying group on Wednesday filed a lawsuit challenging provisions in the Biden administration’s Inflation Reduction Act that will allow Medicare to start negotiating prices for certain drugs.

The lawsuit from the Pharmaceutical Research and Manufacturers of America (PhRMA) argues the law’s signature provision about Medicare negotiation is unconstitutional. PhRMA joined with the National Infusion Center Association (NICA) and the Global Colon Cancer Association (GCCA) to file the suit in the U.S. District Court for the Western District of Texas.

PhRMA CEO Steve Ubl told reporters the provisions amount to “a government mandate disguised as negotiation.”

Read the source article at thehill.com